Abbott Toxicology Uscreen Drug Test Cup

Yes, the Abbott Toxicology Uscreen Drug Test Cup is available in specific CLIA Waived configurations.

While not all panel combinations carry this designation, many options are designed to meet the Clinical Laboratory Improvement Amendments (CLIA) waiver requirements.

Benefits of CLIA Waived Options

Choosing a CLIA Waived configuration is beneficial because it expands usability, making the tests suitable for use in non-laboratory settings that require waived testing procedures, such as:

• Workplace drug screening
• On-site compliance testing
• Certain clinical diagnostic settings

These cups provide a rapid, qualitative screening test for the immediate detection of multiple drugs of abuse in human urine samples.

Yes, the Abbott Toxicology Uscreen Drug Test Cup is highly versatile, providing rapid, qualitative screening for multiple drugs of abuse in human urine samples.

Versatility and Key Features

• Multi-Panel Options: The cups are available in extensive configurations, ranging from 7-panel up to 14-panel options, accommodating diverse screening needs and allowing users to select the precise profile required.
• Rapid Screening: The cups utilize rapid assay technology to deliver quick, qualitative results based on specified cut-off levels.
• CLIA Waiver Availability: While not all variants are waived, CLIA Waived configurations are available for this test cup, broadening usability in settings that require waived testing complexity.
• Convenient Packaging: All units are designated as Factory New and are packaged efficiently in boxes containing 25 tests per box.

Yes, the Abbott Toxicology Uscreen Drug Test Cup is available in multiple configurations that are CLIA Waived.

This designation signifies that the tests meet the Clinical Laboratory Improvement Amendments (CLIA) waiver criteria, which provides several benefits:

• Simplified Requirements: CLIA Waived tests are suitable for use in facilities with minimal complexity testing requirements.
• Versatile Use: They are often ideal for rapid, point-of-care screening in non-laboratory settings, such as workplace drug testing programs or clinics.

Each box of Abbott Toxicology Uscreen Drug Test Cups contains 25 individual units. This standardized packaging applies across all available multi-panel configurations.

Yes, the Abbott Toxicology Uscreen Drug Test Cup is designed for rapid, qualitative screening. This means the device quickly provides initial results for the detection of multiple drugs of abuse present in human urine samples, utilizing specified cut-off levels. This rapid capability makes it highly effective for professional environments needing efficient, on-site testing.

Yes, all Abbott Toxicology Uscreen Drug Test Cups are supplied in Factory New condition, guaranteeing quality and reliability for diagnostic screening.

The Abbott Toxicology Uscreen Drug Test Cup is highly versatile, offering numerous configurations for rapid, qualitative screening of Drugs of Abuse (DOA) in human urine. You can select the panel breakdown that best suits your requirements.

Key configuration details include:

• Panel Range: Configurations are available ranging from 5-panel up to 14-panel tests (e.g., 7-panel, 12-panel, 14-panel options).
• Drug Targets: Panels are designed to detect a wide spectrum of substances, which may include AMP, BZO, COC, MOP (OPI), MET, and THC, among others.
• CLIA Waiver Status: CLIA Waived configurations are available for select options, providing broader usability in certain clinical settings. Please verify the specific configuration chosen if a CLIA Waived product is required.
• Packaging: All Uscreen Drug Test Cups are consistently packaged with 25 units per box.

The Abbott Toxicology Uscreen Drug Test Cup comes in multiple configurations, and THC (Tetrahydrocannabinol) testing depends entirely on the specific panel you choose.

• Varies by Configuration: While many configurations include THC detection to meet specific protocols, some specialized panels do not include THC detection.
• Verification is Key: Because the specific drugs tested are defined by the configuration variant, you must check the detailed product option name before ordering to ensure it matches your testing requirements.

Yes, the Abbott Toxicology Uscreen Drug Test Cup is designed as a rapid, qualitative screening test for the detection of drugs of abuse (DOA) in human urine. This feature allows for quick results, making it an efficient tool for on-site screening. Many available configurations are also CLIA Waived, simplifying use in various testing environments.

Yes, the Abbott Toxicology Uscreen Drug Test Cup is designed for exceptional versatility, offering a wide range of multi-panel configurations to suit diverse screening requirements. This includes options for various panel counts and drug combinations.

Key features regarding configuration:

• Extensive Panel Range: Configurations typically range from 7-panel up to 14-panel tests, allowing for qualitative detection of a broad spectrum of controlled substances in human urine.
• Drug Detection: The panels cover numerous compounds, including AMP (Amphetamines), COC (Cocaine), MOP (Opiates), THC (Marijuana), MET (Methamphetamines), and BZO (Benzodiazepines), among others.
• CLIA Waiver: It is important to note that many configurations of the Uscreen cup are CLIA Waived, broadening their usability in various settings like workplace screening and clinical environments.

All units are designated as Factory New and are consistently packaged in boxes of 25 tests per unit.